Lekakis J, Mavrikakis M, Prassopoulos V, Gerali S, Sifakis N, Kostamis P, Stamatelopoulos S
Department of Clinical Therapeutics Athens University, Greece.
J Nucl Cardiol. 1999 Jan-Feb;6(1 Pt 1):91-2. doi: 10.1016/s1071-3581(99)90069-7.
In-antimyosin scintigraphy offers a valuable noninvasive method for early detection of clinically silent cardiac involvement in patients with systemic sclerosis, even in the absence of left ventricular dysfunction. In these patients with positive antimyosin study results, intense pharmacologic treatment with vasodilators may be warranted.
抗肌凝蛋白闪烁扫描术为早期检测系统性硬化症患者临床上无症状的心脏受累情况提供了一种有价值的非侵入性方法，即便患者不存在左心室功能障碍。对于抗肌凝蛋白研究结果呈阳性的这些患者，可能有必要采用血管扩张剂进行强化药物治疗。
